Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
- Market Cap ₹ 53.2 Cr.
- Current Price ₹ 32.0
- High / Low ₹ 50.0 / 30.0
- Stock P/E 6.48
- Book Value ₹ 52.5
- Dividend Yield 1.10 %
- ROCE 24.5 %
- ROE 18.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.61 times its book value
- Company has delivered good profit growth of 146% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.4%
Cons
- Promoter holding has decreased over last quarter: -2.78%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 50.64 | 59.89 | |
| 27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.00 | 31.14 | 40.57 | 48.45 | |
| Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 8.15 | 8.79 | 10.07 | 11.44 |
| OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 22.01% | 19.89% | 19.10% |
| 0.00 | 0.83 | 0.01 | 0.01 | 0.00 | -0.97 | 0.00 | 0.01 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.13 | 0.12 |
| Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.27 | 0.36 |
| Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 6.99 | 8.28 | 9.68 | 10.96 |
| Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | 25.21% | |
| 0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.20 | 7.24 | 8.20 | |
| EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 6.26 | 7.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 19% |
| TTM: | 34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 146% |
| 3 Years: | 52% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | 25% |
| Last Year: | 18% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 | 11.56 |
| Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 31.16 | 49.12 |
| 2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.58 | 1.04 | 1.22 | |
| 1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.51 | 4.58 | 5.00 | |
| Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 | 66.90 |
| 2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 6.64 | 6.82 | |
| CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 | 0.00 | 0.68 |
| 8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 41.70 | 59.40 | |
| Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 | 66.90 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.96 | 5.48 | ||
| 0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.43 | -7.13 | ||
| 0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | 0.03 | ||
| Net Cash Flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 | -1.62 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.90 | 68.26 |
| Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 | 127.15 |
| Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 | 12.32 |
| Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.26 | 183.09 |
| Working Capital Days | 91.35 | 59.59 | 54.14 | 74.85 | 71.64 | 121.57 | 212.07 | 181.85 |
| ROCE % | 0.68% | 1.12% | 35.91% | 63.26% | 32.39% | 24.48% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Animal and Poultry Healthcare Distributors Number |
|
||
| Human Healthcare Distributors Number |
|||
| Human Resource Strength (Employees) Number |
|||
| Number of Export Countries Number |
|||
| Number of Formulations Number |
|||
| Trade Receivable Turnover Ratio Ratio |
|||
Documents
Announcements
-
Intimitation Under Regulation 30 Third Party Food Safety Audit Under FSSAI Regulatory Framework
1d - FSSAI third-party audit: manufacturing facility scored 81/86 (94%), awarded A+ on 18-Mar-2026.
-
Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements) Regulation 2015 - Appointment Of Investor Relation And Public Relation Authority
13 Mar - Shelter Pharma appointed Financial Mindss as Investor Relations and Public Relations agency on March 13, 2026.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
12 Mar - Shelter Pharma secured $18,300 UAE order from First Vet for veterinary healthcare products, to be executed within six months.
-
Announcement under Regulation 30 (LODR)-Conversion of Securities
7 Mar - 2,79,000 warrants converted into equity; Rs.88,40,812.50 received; shares allotted March 7, 2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, March 07, 2026
7 Mar - Converted 2,79,000 warrants into 2,79,000 equity shares; Rs.88,40,812.50 received; paid-up capital increased on 07-Mar-2026.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals